Literature DB >> 6147710

Cyclosporin blood levels do correlate with clinical complications.

E Irschik, H Tilg, D Niederwieser, G Gastl, C Huber, R Margreiter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147710     DOI： 10.1016/s0140-6736(84)91244-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Optimisation of immunosuppressive therapy using pharmacokinetic principles.

Authors:  J Grevel
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

2.  Blood cyclosporin concentrations and renal allograft dysfunction.

Authors:  D W Holt; J T Marsden; A Johnston; M Bewick; D H Taube
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

Review 3.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

4.  The effect of food and bile acid administration on the relative bioavailability of cyclosporin.

Authors:  A Lindholm; S Henricsson; R Dahlqvist
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

5.  Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.

Authors:  J Grevel; E Nüesch; E Abisch; K Kutz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Severe dermatomyositis treated with cyclosporin A.

Authors:  L Ejstrup
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

7.  A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.

Authors:  A Lindholm; R Dahlqvist; G G Groth; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

8.  Effects of cyclosporine A on chick osteoclasts in vitro.

Authors:  M H Chowdhury; V Shen; D W Dempster
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

Review 9.  Therapeutic monitoring of cyclosporin--an update.

Authors:  A Lindholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Very low-dose cyclosporin treatment of steroid-resistant interstitial pneumonitis associated with Sjögren's syndrome.

Authors:  H Ogasawara; M Sekiya; A Murashima; T Hishikawa; Y Tokano; I Sekigawa; N Iida; H Hashimoto; S Hirose
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.